G

GlaxoSmithKline Pharmaceuticals Ltd

Pharmaceuticals

MIDCAP

Pharmaceuticals

Live Performance vs 

This is a tool to communicate factual return information and should not be seen as an advertisement or promotion

Analyst Ratings and Key Metrics

Based on 4 analysts offering recommendations for GlaxoSmithKline Pharmaceuticals Ltd

75%

Buy

25%

Hold

0%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio79.0147.25
PB Ratio26.226.02
Dividend Yield1.16%0.55%

Understand what these metrics mean. 

About the company

G

GlaxoSmithKline Pharmaceuticals Ltd

GlaxoSmithKline Pharmaceuticals is a pharmaceutical company engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in pharmaceuticals, va...
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions